Hydroxocobalamin Therapy

Hydroxocobalamin Therapy is a form of antidote therapy that specifically involves the administration of hydroxocobalamin, a vitamin B12 precursor, to neutralize cyanide poisoning by binding cyanide ions to form cyanocobalamin, which is then excreted renally.

283

Publications

11K

Citations

1.1K

Authors

424

Institutions

Publications per year

2017–2026

50

Authors

1.1K

  1. VS
    Vikhyat S. Bebarta

    Brooke Army Medical Center, United States

    10 publications · 321 citations

    10

    h-index

  2. FJ
    Frédéric J. Baud

    Université Paris Cité, France

    9 publications · 649 citations

    9

    h-index

  3. SW
    Stephen W. Borron

    Hôpital Fernand-Widal, France

    8 publications · 578 citations

    8

    h-index

  4. HR
    Helen R. Skeggs

    United States Military Academy, United States

    5 publications · 110 citations

    5

    h-index

  5. PH
    Paul Houeto

    Hôpital Fernand-Widal, France

    5 publications · 200 citations

    5

    h-index

1–5 of 1.1K

Venues

  1. PubMed

    Repository · 28 publications · 773 citations

    16

    h-index

  2. Clinical Toxicology

    12 publications · 667 citations

    12

    h-index

  3. Blood

    10 publications · 1.1K citations

    10

    h-index

  4. 9

    h-index

  5. The Lancet

    8 publications · 269 citations

    8

    h-index

1–5